69 related articles for article (PubMed ID: 18775779)
41. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.
van Zanden JJ; Wortelboer HM; Bijlsma S; Punt A; Usta M; Bladeren PJ; Rietjens IM; Cnubben NH
Biochem Pharmacol; 2005 Feb; 69(4):699-708. PubMed ID: 15670588
[TBL] [Abstract][Full Text] [Related]
42. Influence of t-butylhydroquinone and beta-naphthoflavone on formation and transport of 4-methylumbelliferone glucuronide in Caco-2/TC-7 cell monolayers.
Bock-Hennig BS; Kohle C; Nill K; Bock KW
Biochem Pharmacol; 2002 Jan; 63(2):123-8. PubMed ID: 11841785
[TBL] [Abstract][Full Text] [Related]
43. Design of 3D printed insert for hanging culture of Caco-2 cells.
Shen C; Meng Q; Zhang G
Biofabrication; 2014 Dec; 7(1):015003. PubMed ID: 25514920
[TBL] [Abstract][Full Text] [Related]
44. Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis.
Alsenz J; Haenel E
Pharm Res; 2003 Dec; 20(12):1961-9. PubMed ID: 14725360
[TBL] [Abstract][Full Text] [Related]
45. A Miniaturized Pump Out Method for Characterizing Molecule Interaction with ABC Transporters.
Sevin E; Dehouck L; Versele R; Culot M; Gosselet F
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31698745
[TBL] [Abstract][Full Text] [Related]
46. Inhibitory effect of flavonoids on the efflux of N-acetyl 5-aminosalicylic acid intracellularly formed in Caco-2 cells.
Yoshimura S; Kawano K; Matsumura R; Sugihara N; Furuno K
J Biomed Biotechnol; 2009; 2009():467489. PubMed ID: 19688110
[TBL] [Abstract][Full Text] [Related]
47. Prediction model of human ABCC2/MRP2 efflux pump inhibitors: a QSAR study.
Le MT; Phan TV; Tran-Nguyen VK; Tran TD; Thai KM
Mol Divers; 2021 May; 25(2):741-751. PubMed ID: 32048150
[TBL] [Abstract][Full Text] [Related]
48. Transport-Mediated Oxaliplatin Resistance Associated with Endogenous Overexpression of MRP2 in Caco-2 and PANC-1 Cells.
Biswas R; Bugde P; He J; Merien F; Lu J; Liu DX; Myint K; Liu J; McKeage M; Li Y
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31500349
[TBL] [Abstract][Full Text] [Related]
49. Non-Invasive Microbial Metabolic Activity Sensing at Single Cell Level by Perfusion of Calcein Acetoxymethyl Ester.
Krämer CE; Singh A; Helfrich S; Grünberger A; Wiechert W; Nöh K; Kohlheyer D
PLoS One; 2015; 10(10):e0141768. PubMed ID: 26513257
[TBL] [Abstract][Full Text] [Related]
50. pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1.
Varma MV; Rotter CJ; Chupka J; Whalen KM; Duignan DB; Feng B; Litchfield J; Goosen TC; El-Kattan AF
Mol Pharm; 2011 Aug; 8(4):1303-13. PubMed ID: 21710988
[TBL] [Abstract][Full Text] [Related]
51. Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications.
Naseem A; Pal A; Gowan S; Asad Y; Donovan A; Temesszentandrási-Ambrus C; Kis E; Gaborik Z; Bhalay G; Raynaud F
Cells; 2022 Oct; 11(20):. PubMed ID: 36291153
[TBL] [Abstract][Full Text] [Related]
52. Cellular Pharmacokinetic Model-Based Analysis of Genistein, Glyceollin, and MK-571 Effects on 5 (and 6)-Carboxy-2',7'-Dichloroflourescein Disposition in Caco-2 Cells.
Drennen C; Gorse E; Stratford RE
J Pharm Sci; 2018 Apr; 107(4):1194-1203. PubMed ID: 29247742
[TBL] [Abstract][Full Text] [Related]
53. Advancement of structure-activity relationship of multidrug resistance-associated protein 2 interactions.
Xing L; Hu Y; Lai Y
AAPS J; 2009 Sep; 11(3):406-13. PubMed ID: 19495992
[TBL] [Abstract][Full Text] [Related]
54. A Caco-2 cell based screening method for compounds interacting with MRP2 efflux protein.
Siissalo S; Hannukainen J; Kolehmainen J; Hirvonen J; Kaukonen AM
Eur J Pharm Biopharm; 2009 Feb; 71(2):332-8. PubMed ID: 18775779
[TBL] [Abstract][Full Text] [Related]
55. Characterization of 5(6)-carboxy-2,'7'-dichlorofluorescein transport by MRP2 and utilization of this substrate as a fluorescent surrogate for LTC4.
Heredi-Szabo K; Kis E; Molnar E; Gyorfi A; Krajcsi P
J Biomol Screen; 2008 Apr; 13(4):295-301. PubMed ID: 18349419
[TBL] [Abstract][Full Text] [Related]
56. Characterization of rhodamine-123, calcein and 5(6)-carboxy-2',7'-dichlorofluorescein (CDCF) export via MRP2 (ABCC2) in MES-SA and A549 cells.
Munić V; Hlevnjak M; Eraković Haber V
Eur J Pharm Sci; 2011 Aug; 43(5):359-69. PubMed ID: 21605668
[TBL] [Abstract][Full Text] [Related]
57. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells.
Prime-Chapman HM; Fearn RA; Cooper AE; Moore V; Hirst BH
J Pharmacol Exp Ther; 2004 Nov; 311(2):476-84. PubMed ID: 15210835
[TBL] [Abstract][Full Text] [Related]
58. Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport.
Pratt S; Chen V; Perry WI; Starling JJ; Dantzig AH
Eur J Pharm Sci; 2006 Apr; 27(5):524-32. PubMed ID: 16337112
[TBL] [Abstract][Full Text] [Related]
59. The Caco-2 cell monolayer: usefulness and limitations.
Sun H; Chow EC; Liu S; Du Y; Pang KS
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):395-411. PubMed ID: 18433344
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
